Overview
The goal of this clinical trial is to investigate the influence of ultrasound on cardiac functrion.
The main question it aims to answer is:
How will ultrasound affect the cardiac function?
Researchers will： Apply ultrasound to the body and observe cardiac functions.
Participants will:
Receive ultrasound application and physiological signal monitoring.
Description
All procedures conducted in this trial comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All procedures were approved by the Research Ethics Committee of ShanghaiTech University (Q2024-004).
The primary outcome is heart rhythm. It will be measured by electrocardiogram. The secondary primary outcome is the incidence of treatment-related adverse events. It will be measured by electrocardiogram and observation.
Eligibility
Inclusion Criteria:
- Healthy individuals without significant diseases or chronic conditions.
- Aged between 18 and 65 years.
- Voluntary participation with signed informed consent.
- No history of cardiovascular disease.
Exclusion Criteria:
- Individuals with heart disease or other conditions that may affect cardiac function measurement.
- Individuals with implanted electronic devices such as pacemakers or defibrillators.
- Those on medications that significantly alter heart rate, such as beta-blockers, unless under stable control for a specific period.
- Individuals at risk of severe complications.